The challenges of overcoming antibiotic resistance: Plant extracts as potential sources of antimicrobial and resistance modifying agents

African Journal of Biotechnology

Volumn 6, Issue 25, 2007, Pages 2886-2896

  Sibanda, T ^a   Okoh, A I ^a  

^a UNIVERSITY OF FORT HARE   (South Africa)

Author keywords

Antibiotic resistance; Plant extracts; Resistance modifying agents

Indexed keywords

5 METHOXYHYDROCARPIN D; ALKALOID DERIVATIVE; AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BERBERINE; CAPREOMYCIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; COUMARIN DERIVATIVE; EPIGALLOCATECHIN GALLATE; ERYTHROMYCIN; FLAVONE DERIVATIVE; FLAVONOID; GENTAMICIN; ISONIAZID; KANAMYCIN; LINEZOLID; LUTEOLIN; OXACILLIN; PHENOL DERIVATIVE; PHEOPHORBIDE A; PLANT EXTRACT; RIFAMPICIN; TANNIN DERIVATIVE; TERPENE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN;

ACORUS CALAMUS; AFRICA; ANTIBIOTIC RESISTANCE; AQUILEGIA VULGARIS; ASPHODELUS MICROCARPUS; BACTERIAL CELL; BIOSPHERE; CAESALPINIA SPINOSA; CALOPHYLLUM BRASILIENSE; CHAMAECYPARIS LAWSONIANA; CLOVE; CYMBOPOGON CITRATUS; DEGRADATION; ESCHERICHIA COLI; EUCALYPTUS MACULATE; GARCINIA KOLA; GARLIC; GINGER; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GUAVA; HEMIDESMUS INDICUS; HOLARRHENA ANTIDYSENTERICA; HUMAN; IN VITRO STUDY; INFECTION; ISATIS TINCTORIA; JATROPHA ELLIPTICA; LYCOPUS EUROPAEUS; MAHONIA AQUIFOLIUM; MEDICINAL PLANT; MIKANIA GLOMERATA; MULTIDRUG RESISTANCE; MYCOBACTERIUM; NONHUMAN; PAEDERIA SCANDENS; PHENOTYPE; PLUMBAGO ZEYLANICA; POMEGRANATE; PSEUDOMONAS AERUGINOSA; REVIEW; ROSEMARY; SALVIA VIRIDIS; SCUTELLARIA BAICALENSIS; SENNA PETERSIANA; STAPHYLOCOCCUS AUREUS; TARAXACUN MONLICUM; TEA;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; ESCHERICHIA COLI; NEGIBACTERIA; POSIBACTERIA; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

EID: 38049132540     PISSN: None     EISSN: 16845315     Source Type: Journal    
DOI: None     Document Type: Review

References (101)

1. Ahmad I, Aqil F (2006). In vitro efficacy of bioactive extracts of 15 Medicinal plants against ESβL-producing multidrug-resistant enteric bacteria. Microbio. Res., pp. 1-12.
2. Akama H, Kanemaki M, Tsukihara T, Nakagawa A, Nakae T (2005). Preliminary crystallographic analysis of the antibiotic discharge outer membrane lipoprotein OprM of Pseudomonas aeruginosa with an exceptionally long unit cell and complex lattice structure. Acta Cryst. F61: 131-133.
3. Akama H, Matsuura T, Kashiwagi S, Yoneyama H, Narita S, Tsukihara T, Nakagawa A, Nakae T (2004). Crystal Structure of the Membrane Fusion Protein, MexA, of the Multidrug Transporter in Pseudomonas aeruginosa. J. Bio. Chem. 279(25): 25939-25942.
4. Al-hebshi N, Al-haroni M, Skaug N (2006). In vitro antimicrobial and resistance-modifying activities of aqueous crude khat extracts against oral microorganisms. Arch. Oral Biol. 51: 183-188.
5. Baucheron S, Tyler S, Boyd D, Mulvey MR, Chaslus-Dancla E, Cloeckaert A (2004). AcrAB-TolC Directs Efflux-Mediated Multidrug Resistance in Salmonella enterica Serovar Typhimurium DT104. Antimicro. Agents Chemother. 48(10): 3729-3735.
6. Bayer AS, Chow AW, Morrison JO, Guze LB (1980). Bactericidal synergy between penicillin or ampicillin and aminoglycosides against antibiotic-tolerant lactobacilli. Antimicrob. Agents Chemother. 17(3): 359-363.
7. Betoni JEC, Mantovani RP, Barbosa LN, Di-Stasi LC, Fernandes A (2006). Synergism between plant extract and antimicrobial drugs used on Staphylococcus aureus diseases. Mem. Inst. Oswaldo Cruz. 101 No. 4.
8. Braga LC, Leite AAM, Xavier KGS, Takahashi JA, Bemquerer MP, Chartone-Souza E, Nascimento AMA (2005). Synergic interaction between pomegranate extract and antibiotics against Staphylococcus aureus. Can. J. Microbio. 51(7): 541-547.
9. Brown MH, Skurray RA (2001). Staphylococcal multidrug efflux protein QacA. J. Mol. Microbiol. Biotechnol. 3(2): 163-170.
10. Bush K (2004). Antibacterial drug discovery in the 21st century. Clin. Microbiol. Inf., 10(s4): 10-17.
11. Bylka W, Szaufer-Hajdrych M, Matlawska I, Goslinska O (2004). Antimicrobial activity of isocytisoside and extracts of Aquilegia vulgaris L. Lett. Appl. Microbiol. 39(1): 93-97.
12. Cernakova M, Kostalova D (2002). Antimicrobial activity of berberine, a constituent of Mahonia aquifolium. Folia Microbiol. (Praha). 47(4): 375-378.
13. Coates A, Hu Y, Bax R, Page C (2002). The future challenges facing the development of new antimicrobial drugs. Nat. Rev. Drug Discov. 1: 895-910.
14. Cottagnoud P, Acosta F, Cottagnoud M, Neftel K, Tauber MG (2000). Synergy between Trovafloxacin and Ceftriaxone against Penicillin-Resistant Pneumococci in the Rabbit Meningitis Model and In Vitro. Antimicrob. Agents Chemother. 44(8): 2179-2181.
15. Cowan MM (1999). Plant Products as Antimicrobial Agents. Clin. Microbiol Rev 12(4): 564-582.
16. Darwish RM, Aburjai T, Al-Khalil S, Mahafzah A (2002). Screening of antibiotic resistant inhibitors from local plant materials against two different strains of Staphylococcus aureus. J. Ethnopharm. 79: 359-364.
17. Davies J (1994). Inactivation of antibiotics and the dissemination of resistance genes. Science. 264: 375-382.
18. Dickson RA, Houghton PJ, Hylands PJ, Gibbons S (2006). Antimicrobial, resistance-modifying effects, antioxidant and free radical scavenging activities of Mezoneuron benthamianum Baill, Securinega virosa Roxb. and Wlld. and Microglossa pyrifolia Lam. Phytother Res. 20(1): 41-45.
19. Dryselius R, Nekhotiaeva N, Good L (2005). Antimicrobial synergy between mRNA- and protein-level inhibitors. J. Antimicrob. Chemother. 56(1): 97-103.
20. El-Seedi HR (2007). Antimicrobial Arylcoumarins from Asphodelus microcarpus. J. Nat. Prod., 1: 118-120.
21. Frere JM (1995). Beta-lactamases and bacterial resistance to antibiotics. Mol. Microbiol. 16(3): 385-395.
22. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland G (2006). Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. The Lancet. 368: 1575-1580.
23. Gibbons S (2004). Anti-staphylococcal plant natural products. Nat. Prod. Rep., 21: 263-277.
24. Gibbons S, Moser E, Kaatz GW (2004). Catechin gallates inhibit multidrug resistance (MDR) in Staphylococcus aureus. Planta Med. 70(12): 1240-1242.
25. Gibbons S, Oluwatuyi M, Veitch NC, Gray AI, (2003). Bacterial resistance modifying agents from Lycopus europaeus. Phytochem. 62 (1): 83-87.
26. Gill MJ, Brenwald NP, Wise R (1999). Identification of an efflux pump gene pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 43: 187-189.
27. Golemi-Kotra D, Cha JY, Meroueh SO, Vakulenko SB, Mobashery S (2003). Resistance to β-Lactam Antibiotics and Its Mediation by the Sensor Domain of the Transmembrane BlaR Signaling Pathway in Staphylococcus aureus. J. Biol. Chem. 278(20): 18419-18425.
28. Grebe T, Hakenbeck R (1996). Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary resistance determinants for different classes of beta-lactam antibiotics. Antimicrob. Agents Chemother. 40(4): 829-834.
29. Hallander HO, Dornbusch K, Gezelius L, Jacobson K, Karlsson I (1982). Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method. Antimicrob. Agents Chemother. 22(5): 743-752.
30. Hamilton-Miller JM (1995). Antimicrobial properties of tea (Camellia sinensis L.) Antimicrob. Agents Chemother. 39(11): 2375-2377.
31. Han QB, Lee SF, Qiao CF, He ZD, Song JZ, Sun HD, Xu HX (2005). Complete NMR Assignments of the Antibacterial Biflavonoid GB1 from Garcinia kola. Chem. Pharm. Bull. 53(8): 1034-1036.
32. Hancock EW (2005). Mechanisms of action of newer antibiotics for Gram-positive pathogens. Lancet Infect. Dis. 5(4): 209-218.
33. Hernandez SP (2005). Responsible use of antibiotics in aquaculture. FAO Fisheries Technical paper 469.
34. Hooper DC (2005). Efflux Pumps and Nosocomial Antibiotic Resistance: A Primer for Hospital Epidemiologists. Healthcare Epidemiol. 40: 1811-1817.
35. Hooton TM, Blair AD, Turck M, Counts GW (1984). Synergism at clinically attainable concentrations of aminoglycoside and beta-lactam antibiotics. Antimicrob. Agents Chemother. 26(4): 535-538.
36. Hu ZQ, Zhao WH, Asano N, Yoda Y, Hara Y, Shimamura T (2002). Epigallocatechin gallate synergistically enhances the activity of carbapenems against methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 46(2): 558-560.
37. Iwu MW, Duncan AR, Okunji CO (1999). New antimicrobials of plant origin. Janick J (ed.), Perspectives on new crops and new uses, pp. 457-462.
38. Jerry D, Smilack MD (1999). Trimethoprim-Sulfamethoxazole. Mayo Clin. Proc. 74: 730-734.
39. Kaatz GW (2002). Inhibition of bacterial efflux pumps: a new strategy to combat increasing antimicrobial agent resistance. Expert. Opin. Emerg. Drugs. 7(2): 223-233.
40. Kaatz GW, Seo SM (1995). Inducible NorA-mediated multidrug resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 39(12): 2650-2655.
41. Kaatz GW, Seo SM, Ruble CA (1993). Efflux-Mediated Fluoroquinolone Resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 37(5): 1086-1094.
42. Kataja J, Seppala H, Skurnik M, Sarkkinen H, Huovinen P (1998). Different Erythromycin Resistance Mechanisms in Group C and Group G Streptococci. Antimicrob. Agents Chemother. 42(6): 1493-1494.
43. Kohler T, Pechere JC, Plesiat P (1999). Bacterial antibiotic efflux systems of medical importance. Cell. Mol. Life Sci. 56: 771-778.
44. Kumar A, Schweizer HP (2005). Bacterial resistance to antibiotics: Active efflux and reduced uptake. Adv. Drug Deliv. Rev. 57: 1486-1513.
45. Lambert PA (2005). Bacterial resistance to antibiotics: Modified target sites. Adv. Drug Deliv. Rev. 57(10): 1471-1485.
46. Levy SB, Marshall B (2004). Antibacterial resistance worldwide: causes, challenges and responses. Nat. Med. 10: S122-S129.
47. Lewis K, Ausubel FM (2006). Prospects for plant-derived antibacterials. Nat. Biotechnol. 24(12): 1504-1507.
48. Li XZ, Livermore DM, Nikaido H (1994a). Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob. Agents Chemother. 38(8): 1732-1741.
49. Li XZ, Ma D, Livermore DM, Nikaido H (1994b). Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to beta-lactam resistance. Antimicrob. Agents Chemother. 38(8): 1742-1752.
50. Lin J, Michel LO, Zhang Q (2002). Cme ABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob. Agents Chemother. 46: 2124-2131.
51. Lomovskaya O, Bostian KA (2006). Practical applications and feasibility of efflux pump inhibitors in the clinic - A vision for applied use. Biochem Pharmacol. 7(1): 910-918.
52. Mabe K, Yamada M, Oguni I, Takahashi T (1999). In Vitro and In Vivo Activities of Tea Catechins against Helicobacter pylori. Antimicrob. Agents Chemother. 43(7): 1788-1791.
53. Machado TB, Leal ICR, Amaral ACF, Santos KRN, Silva MG, Kuster RM (2002). Antimicrobial Ellagitannin of Punica granatum Fruits. J. Braz. Chem. Soc. 13(5): 606-610.
54. Maddux MS (1991). Effects of beta-lactamase-mediated antimicrobial resistance: the role of beta-lactamase inhibitors. Pharmacother. 11(2): 40S-50S.
55. Madubunyi II (1995). Antimicrobial activities of the constituents of Garcinia Kola Seeds. Int. J. Pharmacog. 33(3): 232-237.
56. Marquez B (2005). Bacterial efflux systems and efflux pumps inhibitors. Biochimie 87(12): 1137-1147.
57. Marquez B, Neuville L, Moreau NJ, Genet JP, Santos AF, Andrade MCC, Sant Ana AEG (2005). Multidrug resistance reversal agent from Jatropha elliptica. Phytochem. 66: 1804-1811.
58. Masi M, Pages JM, Pradel E (2003). Overexpression and purification of the three components of the Enterobacter aerogenes AcrA-AcrB-TolC multidrug efflux pump. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 786(1-2): 197-205.
59. Matic V, Bozdogan B, Jacobs MR, Ubukata K, Appelbaum PC (2003). Contribution of beta-lactamase and PBP amino acid substitutions to amoxicillin/clavulanate resistance in beta-lactamase-positive, amoxicillin/clavulanate-resistant Haemophilus influenzae. J. Antimicrob. Chemother. 52(6): 1018-1021.
60. McKeegan KS, Borges-Walmsley MI, Walmsley AR (2004). Structural understanding of efflux-mediated drug resistance: potential routes to efflux inhibition. Curr. Opin. Pharmacol. 4(5): 479-486.
61. Mine T, Morita Y, Kataoka A, Mizushima T, Tsuchiya T (1999). Expression in Escherichia coli of a New Multidrug Efflux Pump, MexXY from Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 43(2): 415-417.
62. Mitchell BA, Brown MH, Skurray RA (1998). QacA Multidrug Efflux Pump from Staphylococcus aureus: Comparative Analysis of Resistance to Diamidines, Biguanidines, and Guanylhydrazones, Antimicrob. Agents Chemother. 42(2): 475-477.
63. Moosdeen F, Williams JD, Yamabe S (1988). Antibacterial characteristics of YTR 830, a sulfone beta-lactamase inhibitor, compared with those of clavulanic acid and sulbactam. Antimicrob. Agents Chemother. 32(6): 925-927.
64. Nakaido H (1994). Prevention of drug access to bacterial targets: Permeability barriers and active efflux. Science. 264: 382-388.
65. Neu HC, Wilson AP, Gruneberg RN (1993). Amoxycillin/clavulanic acid: a review of its efficacy in over 38,500 patients from 1979 to 1992. J. Chemother. 5(2): 67-93.
66. Norrby RS, Nord CE, Finch R (2005). Lack of development of new antimicrobial drugs: a potential serious threat to public health. The Lancet Infect. Dis. 5(2): 115-119.
67. Nostro A, Germarno MP, D'Angelo V, Marino A, Canatelli MA (2000). Extraction methods and bioautography for evaluation of medicinal plant antimicrobial activity. Lett. Appl. Microbiol. 30: 379-384.
68. Oluwatuyi M, Kaatz GW, Gibbons S (2004). Antibacterial and resistance modifying activity of Rosmarinus officinalis. Phytochemistry 65(24): 3249-3254.
69. Over U, Gur D, Unal S, Miller GH, Aminoglycoside Resistance Study Group (2001). The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey. Clin. Microbiol. Infection. 7(9): 470-478.
70. Pankey G, Ascraft D, Patel N (2005). In vitro synergy of daptomycin plus rifampin against Enterococcus faecium resistant to both linezolid and vancomycin. Antimicrob. Agents Chemother. 49(12): 5166-5168.
71. Paulsen IT, Sliwinski MK, Saier Jr MH (1998). Microbial genome analyses: global comparisons of transport capabilities based on phylogenies, bioenergetics and substrate specificities. J. Mol. Biol. 277: 573-592.
72. Pradel E, Pages JM (2002). The AcrAB-TolC efflux pump contributes to multidrug resistance in the nosocomial pathogen Enterobacter aerogenes. Antimicrob. Agents Chemother. 46(8): 2640-22643.
73. Pretto JB, Cechinel-Filho V, Noldin VF, Sartori MRK, Isaias DEB, Cruz AB (2004). Antimicrobial activity of fractions and compounds from Calophyllum brasiliense (Clusiaceae/Guttiferae). J. Biosci. 59(9-10): 657-662.
74. Reading C, Cole M (1977). Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerus. Antimicrob. Agents Chemother. 11(5): 852-857.
75. Roberts MC, Sutcliffe J, Courvalin P, Jensen LB, Rood J, Seppala H (1999). Nomenclature for Macrolide and Macrolide-Lincosamide-Streptogramin B Resistance Determinants. Antimicrob. Agents Chemother. 43(12): 2823-2830.
76. Rossolini GM, Mantengoli E (2005). Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin. Microb. Infect. 11(s4): 17-32.
77. Sanchez L, Pan W, Vinas M, Nikaido H (1997). The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump. J. Bacteriol. 179(21): 6855-6857.
78. Seppala H, Skurnik M, Soini H, Roberts MC, Huovinen P (1998). A Novel Erythromycin Resistance Methylase Gene (ermTR) in Streptococcus pyogenes. Antimicrob. Agents Chemother. 42(2): 257-262.
79. Shibata H, Kondo K, Katsuyama R, Kawazoe K, Sato Y, Murakami K, Takaishi Y, Arakaki N, Higuti T (2005). Alkyl Gallates, Intensifiers of β-Lactam Susceptibility in Methicillin-Resistant Staphylococcus aureus Antimicrob. Agents Chemother. 49(2): 549-555.
80. Si W, Gong J, Tsao R, Kalab M, Yang R, Yin Y (2006). Bioassay-guided purification and identification of antimicrobial components in Chinese green tea extract J. Chromatogr. A: 1125(2): 204-210.
81. Smith ECJ, Williamson EM, Wareham N, Kaatz GW, Gibbons S (2007). Antibacterials and modulators of bacterial resistance from the immature cones of Chamaecyparis lawsoniana. Phytochem. 68(2): 210-217.
82. Spratt BG (1994). Resistance to antibiotics mediated by target alterations. Science. 264: 388-393.
83. Stapleton PD, Shah S, Anderson JC Hara Y, Hamilton-Miller JMT, Taylor PW (2004). Modulation of β-lactam resistance in Staphylococcus aureus by catechins and gallates. Int. J. Antimicrob. Agents. 23(5): 462-467.
84. Stermitz FR, Lorenz P, Tawara JN, Zenewicz LA, Lewis K (2000a). Synergy in a medicinal plant: Antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor. Appl. Biol. Sci. 97(4): 1433-1437.
85. Stermitz FR, Tawara-Matsuda J, Lorenz P, Mueller P, Zenewicz L, Lewis K (2000b). 5′-Methoxyhydnocarpin-D and Pheophorbide A: Berberis Species Components that Potentiate Berberine Growth Inhibition of Resistant Staphylococcus aureus. J. Nat. Prod. 63(8): 1146-1149.
86. Styers D, Sheehan DJ, Hogan P, Sahm DF (2006). Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann. Clin. Microb. Antimicrob. 5: 2.
87. Sutcliffe J, Tait-Kamradt A, Wondrack L (1996). Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother. 40(8): 1817-1824.
88. Takahashi T, Kokubo R, Sakaino M (2004). Antimicrobial activities of eucalyptus leaf extracts and flavonoids from Eucalyptus maculata. Lett. Appl. Microbiol. 39(1): 60-64.
89. Taylor PW, Stapleton PD, Luzio JP (2002). New ways to treat bacterial infections. DDT. 7(21): 1086-1091.
90. Tegos G, Stermitz FR, Lomovskaya O, Lewis K (2002). Multidrug Pump Inhibitors Uncover Remarkable Activity of Plant Antimicrobials, Antimicrob. Agents Chemother 46(10): 3133-3141.
91. Teran W, Antonia F, Segura A, Rojas A, Ramos JL, Gallegos MT (2003). Antibiotic-dependent induction of Pseudomonas putida DOT-T1E TtgABC efflux pump is mediated by the Drug Binding Repressor TtgR. Antimicrob. Agents Chemother. 47(10): 3067-3072.
92. Touze T, Eswaran J, Bokma E, Koronakis E, Hughes C, Koronakis V (2004). Interactions underlying assembly of the Escherichia coli AcrAB-TolC multidrug efflux system. Mol. Microbiol. 53 (2):697-706.
93. Tshikalange TE, Meyer JJM, Hussein AA (2005). Antimicrobial activity, toxicity and the isolation of a bioactive compound from plants used to treat sexually transmitted diseases. J. Ethnopharmacol. 96(3): 515-519.
94. Ulubelen A, Oksuz S, Kolak U, Bozok-Johansson C, Celik C, Voelter W (2000). Antibacterial diterpenes from the roots of Salvia viridis. Planta Med. 66(5): 458-462.
95. Wilke MS, Lovering AL, Strynadka NCJ (2005). β-Lactam antibiotic resistance: a current structural perspective. Curr. Opin. Microbiol. 8(5): 525-533.
96. World Health Organization (WHO) (2002). Antimicrobial resistance. Fact sheet No. 194.
97. Wright GD (2005). Bacterial resistance to antibiotics: Enzymatic degradation and modification. Adv. Drug Deliv. Rev. 57(10): 1451-1470.
98. Yam TS, Hamilton-Miller JM, Shah S (1998). The effect of a component of tea (Camellia sinensis) on methicillin resistance, PBP2′ synthesis, and beta-lactamase production in Staphylococcus aureus. J. Antimicrob Chemother. 42(2): 211-216.
99. Yang ZC, Wang BC, Yang XS, Wang Q, Ran L (2005). The synergistic activity of antibiotics combined with eight traditional Chinese medicines against two different strains of Staphylococcus aureus. Colloids and surfaces B: Biointerfaces, 41(2-3): 79-81.
100. Zhao WH, Hu ZQ, Okubo S, Hara Y, Shimamura T (2001). Mechanism of synergy between Epigallochatechin gallate and β-Lactams against methicillin resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 45(6): 1737-1742.
101. Ziha-Zarifi I, Llanes C, Kohler T, Pechere JC, Plesiat P (1999). In vivo emergence of multidrug-resistant mutants of Pseudomonas aeruginosa overexpressing the active efflux system MexA-MexB-OprM. Antimicrob. Agents Chemother. 43(2): 287-291.